-
1.
公开(公告)号:WO2023091517A2
公开(公告)日:2023-05-25
申请号:PCT/US2022/050151
申请日:2022-11-16
摘要: Methods are provided for non-invasively determining the expression of genes of interest by inference and the use thereof in disease classification and stratification for treatment. Disclosed methods relate to assessment of fragment length diversity of cell-free DNA, such as determining promoter fragment entropy (PFE). Fragment length diversity scores may be combined with nucleosome depleted region depth to produce a metric that is indicative of gene expression. In some embodiments, the methods use only noninvasive blood draws and identify which patients will achieve durable clinical benefit from immune checkpoint inhibition, what the cancer subtype classification is, and/or what the tumor burden is. In an embodiment, the methods further comprise selecting a treatment regimen for the individual based on the analysis. Also disclosed are bait sets for enrichment of cell-free DNA from regions in proximity with transcription start sites.
-
公开(公告)号:WO2023090388A1
公开(公告)日:2023-05-25
申请号:PCT/JP2022/042675
申请日:2022-11-17
申请人: 富士フイルム株式会社
摘要: 本発明の課題は、難培養性の嫌気性の細菌の生体における生育・増殖環境をin vitroで再現することができる細胞培養装置、細胞培養のためのキット及び細胞培養方法を提供することである。本発明によれば、培地を収容するための凹部を有するプレート、ガス透過膜を有する細胞収容容器、上記細胞収容容器を保持するための第一の部材、及び上記細胞収容容器の上部空間のガス濃度を調節するための構造を有する第二の部材を含む、細胞培養装置であって、上記ガス透過膜の上面に細胞シートを形成した場合には、上記ガス透過膜より上部の空間が、ガスが透過しない密封状態になる、細胞培養装置が提供される。
-
公开(公告)号:WO2023089613A1
公开(公告)日:2023-05-25
申请号:PCT/IL2022/051227
申请日:2022-11-17
申请人: NUCLEIX LTD.
IPC分类号: C12Q1/683
摘要: The invention provides methods for ultra-deep whole-genome sequencing of human DNA. The methods determine the methylation status of millions of sites in the human genome, wherein said methods use few (if any) DNA ammplification cycles.
-
4.
公开(公告)号:WO2023089186A1
公开(公告)日:2023-05-25
申请号:PCT/EP2022/082684
申请日:2022-11-21
发明人: CADY, Kyle C. , CHAN, Ryan , CHIU, Sharon Ho-Chen , LIN, Patrick , MOGHADDASI, Arrash , SPIER, Eugene , SUN, Jingtao
IPC分类号: C12Q1/689
摘要: Methods for the rapid detection of the presence or absence of bacteria having the vanA and/or vanB resistance mechanisms in a biological or non-biological sample are described. The methods can include performing an amplifying step, a hybridizing step, and a detecting step. Furthermore, primers, probes targeting the genes for vanA and vanB, along with kits are provided that are designed for the detection of vanA and vanB.
-
公开(公告)号:WO2023087788A1
公开(公告)日:2023-05-25
申请号:PCT/CN2022/109953
申请日:2022-08-03
申请人: 杨满军
发明人: 杨满军 YANG, Manjun
IPC分类号: C12Q1/6895 , C12Q1/6858 , C12N15/11
摘要: 本发明公开了一种筛选黄绿卷毛菇总可溶性蛋白含量指标的DNA条形码、引物组及应用,属于食用菌种质资源筛选技术领域。本发明在优质黄绿卷毛菇原产地鉴别和遗传育种上发挥作用,同时也为种质资源的鉴定及保护提供了一种方法。
-
公开(公告)号:WO2023087784A1
公开(公告)日:2023-05-25
申请号:PCT/CN2022/109894
申请日:2022-08-03
申请人: 杨满军
发明人: 杨满军 YANG, Manjun
IPC分类号: C12Q1/6895 , C12N15/11 , C12Q1/6858
摘要: 本发明公开了一种筛选黄绿卷毛菇总多酚含量指标的DNA条形码、引物组及应用。本发明的DNA条形码技术具有省时、省力、省钱、准确、高效的优点,在优质黄绿卷毛菇原产地鉴别和遗传育种上发挥积极作用,同时也为种质资源的鉴定及保护提供了一种有效方法。
-
公开(公告)号:WO2023087744A1
公开(公告)日:2023-05-25
申请号:PCT/CN2022/104367
申请日:2022-07-07
申请人: 南京医科大学
IPC分类号: C12Q1/6883 , C12Q1/6851 , C12N15/11 , C12N15/113
摘要: 本发明公开一种鉴别颅缝早闭的血清circRNA标志物及其应用,属于生物技术、预防医学和临床医学领域。该标志物选自hsa_circ_0003568、hsa_circ_0000945中的一种或多种。该标志物组合对颅缝早闭具有特异性和敏感性,可用于颅缝早闭早期诊断或监测的试剂盒,为今后颅缝早闭circRNA的研究提供了理论依据。
-
公开(公告)号:WO2023087105A1
公开(公告)日:2023-05-25
申请号:PCT/CA2022/051694
申请日:2022-11-16
发明人: MAI, Sabine , LOUIS, Sherif , KNECHT, Hans
IPC分类号: C12Q1/6809 , C12Q1/6841 , G16B15/10 , G16B25/00
摘要: Provided are methods for prognosing a clinical outcome in a subject or diagnosing the subject with high-risk or stable smoldering multiple myeloma (SMM), comprising determining a 3D telomeres organization signature of a test sample from the subject, the test sample comprising plasma cells, applying a classification model to the 3D telomeres organization signature to obtain an output classification that is indicative of the clinical outcome or diagnosis of the subject. Also provided are methods for treating a subject with high-risk or stable SMM.
-
9.
公开(公告)号:WO2023086994A1
公开(公告)日:2023-05-19
申请号:PCT/US2022/079819
申请日:2022-11-14
摘要: Disclosed herein are methods of assessing cellular or tissue damage in a patient; methods of identifying a patient having sterile inflammation, methods of assessing sterile inflammation in a patient, methods of monitoring a patient undergoing a treatment with a therapeutic agent that causes cellular or tissue toxicity, methods of treating or preventing cellular or tissue damage in a patient in need thereof, methods of treating or preventing sterile inflammation in a patient in need thereof, and related uses and kits.
-
公开(公告)号:WO2023086950A1
公开(公告)日:2023-05-19
申请号:PCT/US2022/079735
申请日:2022-11-11
发明人: WANG, Liang , MANLEY, Brandon J. , BERGLUND, Anders E. , WANG, Xuefeng , PATEL, Krupal B. , HUANG, Jinyong
IPC分类号: C12Q1/6886 , A61P35/00 , C12N15/10 , C12Q1/6806
摘要: Lung and colorectal cancer are among the most common causes of cancer-related deaths in the US, while pancreatic cancer is the deadliest form of solid malignancy with an alarming 10% five-year survival rate. The dismal mortality rates seen in patients with these malignancies are associated with advanced stage at the time of diagnosis. To improve the outcomes of this patient population, many technologies and assays that enable cancer detection at its early stage have been investigated. What are needed are new proven methods for accurate and early detection of cancer. Disclosed are methods of using cell-free DNA (cfDNA) methylation for the detection, typing, and grading of cancer.
-
-
-
-
-
-
-
-
-